checkAd

     535  0 Kommentare DSM finalizes sale of DSM Synres to Standard Investment

    Royal DSM, the global Life Sciences and Materials Sciences company, today announces it has finalized the sale of DSM Synres to Standard Investment. The divestment was announced on 17 December 2014.

    DSM Synres produces solvent-borne alkyd and acrylic coating resins at its site in Hoek van Holland (Netherlands) for the global coatings, adhesives and graphic arts markets since 1947. DSM Synres realizes sales of approximately €50 million with around 80 employees.

    Standard Investment, based in Amsterdam, is a hands-on private equity firm focused on small and medium-sized enterprises in the Netherlands and Belgium. Since its establishment in 2004, the firm has acquired a portfolio of 18 companies.

    DSM - Bright Science. Brighter Living.(TM)
    Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam. More information can be found at www.dsm.com.

    Or find us on: Title: Facebook - Description: Facebook  Title: Twitter - Description: Twitter  Title: LinkedIn - Description: LinkedIn  Title: YouTube - Description: YouTube 

    For more information:

    DSM Corporate Communications
    Herman Betten
    tel.+31(0)45 5782017 
    email media.contacts@dsm.com
    DSM Investor Relations
    Dave Huizing
    tel.+31(0)45 5782864
    email investor.relations@dsm.com
     


    This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
    The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
    Source: DSM N.V. via Globenewswire

    HUG#1908476



    GlobeNewswire
    0 Follower
    Autor folgen

    Verfasst von GlobeNewswire
    DSM finalizes sale of DSM Synres to Standard Investment Royal DSM, the global Life Sciences and Materials Sciences company, today announces it has finalized the sale of DSM Synres to Standard Investment. The divestment was announced on 17 December 2014. DSM Synres produces solvent-borne alkyd and …